Interestingly, pre-existing peptide-reactive T cell responses (IFN-γ) to MUC1, as measured using quantitative polymerase chain reaction, have been detected in normal donors and in patients with primary breast cancers [45]. This evidence concerns the gene IFNG and breast carcinoma.